APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Montelukast API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Montelukast API Market Analysis and Forecast 2026-2032

Report ID 174014230231 December 2025190 pages

Choose your research edition.

Industry ResearchMontelukast API Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast API Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Montelukast API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Montelukast API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Montelukast API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Montelukast API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Montelukast API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Montelukast API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Montelukast API include Merck, Mylan, Teva Pharmaceutical Industries, Sun Pharma, Sanyo Chemical Industries, Morepen Laboratories, Intas Pharmaceuticals, Delmar Chemicals and Cipla, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Montelukast API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Montelukast API, also provides the sales of main regions and countries. Of the upcoming market potential for Montelukast API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Montelukast API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Montelukast API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Montelukast API sales, projected growth trends, production technology, application and end-user industry.

Montelukast API Segment by Company

Merck

Mylan

Teva Pharmaceutical Industries

Sun Pharma

Sanyo Chemical Industries

Morepen Laboratories

Intas Pharmaceuticals

Delmar Chemicals

Cipla

Apotex

Montelukast API Segment by Type

Chewable Tablet

Oral Solution

Tablet

Montelukast API Segment by Application

Bronchospasm

Urticaria

Asthma

Allergic Rhinitis

Others

Montelukast API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Montelukast API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Montelukast API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Montelukast API sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Montelukast API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chewable Tablet Major Manufacturers Table 3. Oral Solution Major Manufacturers Table 4. Tablet Major Manufacturers Table 5. Global Montelukast API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Bronchospasm Major Manufacturers Table 7. Urticaria Major Manufacturers Table 8. Asthma Major Manufacturers Table 9. Allergic Rhinitis Major Manufacturers Table 10. Others Major Manufacturers Table 11. Montelukast API Industry Trends Table 12. Montelukast API Industry Drivers Table 13. Montelukast API Industry Opportunities and Challenges Table 14. Montelukast API Industry Restraints Table 15. Global Montelukast API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Montelukast API Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Montelukast API Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Montelukast API Revenue Market Share by Region (2021-2026) Table 19. Global Montelukast API Revenue Market Share by Region (2027-2032) Table 20. Global Montelukast API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Montelukast API Sales by Region (2021-2026) & (K Units) Table 22. Global Montelukast API Sales by Region (2027-2032) & (K Units) Table 23. Global Montelukast API Sales Market Share by Region (2021-2026) Table 24. Global Montelukast API Sales Market Share by Region (2027-2032) Table 25. Global Montelukast API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Montelukast API Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Montelukast API Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Montelukast API Sales Market Share by Manufacturers (2021-2026) Table 29. Global Montelukast API Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Montelukast API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Montelukast API Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Montelukast API Manufacturers, Product Type & Application Table 33. Global Montelukast API Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Montelukast API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Montelukast API Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Montelukast API Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Montelukast API Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Montelukast API Revenue Market Share by Type (2021-2026) Table 40. Global Montelukast API Revenue Market Share by Type (2027-2032) Table 41. Global Montelukast API Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Montelukast API Sales by Type (2021-2026) & (K Units) Table 43. Global Montelukast API Sales by Type (2027-2032) & (K Units) Table 44. Global Montelukast API Sales Market Share by Type (2021-2026) Table 45. Global Montelukast API Sales Market Share by Type (2027-2032) Table 46. Global Montelukast API Price by Type (2021-2026) & (US$/Unit) Table 47. Global Montelukast API Price by Type (2027-2032) & (US$/Unit) Table 48. Global Montelukast API Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Montelukast API Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Montelukast API Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Montelukast API Revenue Market Share by Application (2021-2026) Table 52. Global Montelukast API Revenue Market Share by Application (2027-2032) Table 53. Global Montelukast API Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Montelukast API Sales by Application (2021-2026) & (K Units) Table 55. Global Montelukast API Sales by Application (2027-2032) & (K Units) Table 56. Global Montelukast API Sales Market Share by Application (2021-2026) Table 57. Global Montelukast API Sales Market Share by Application (2027-2032) Table 58. Global Montelukast API Price by Application (2021-2026) & (US$/Unit) Table 59. Global Montelukast API Price by Application (2027-2032) & (US$/Unit) Table 60. Merck Company Information Table 61. Merck Business Overview Table 62. Merck Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Merck Montelukast API Product Portfolio Table 64. Merck Recent Development Table 65. Mylan Company Information Table 66. Mylan Business Overview Table 67. Mylan Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Mylan Montelukast API Product Portfolio Table 69. Mylan Recent Development Table 70. Teva Pharmaceutical Industries Company Information Table 71. Teva Pharmaceutical Industries Business Overview Table 72. Teva Pharmaceutical Industries Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Teva Pharmaceutical Industries Montelukast API Product Portfolio Table 74. Teva Pharmaceutical Industries Recent Development Table 75. Sun Pharma Company Information Table 76. Sun Pharma Business Overview Table 77. Sun Pharma Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sun Pharma Montelukast API Product Portfolio Table 79. Sun Pharma Recent Development Table 80. Sanyo Chemical Industries Company Information Table 81. Sanyo Chemical Industries Business Overview Table 82. Sanyo Chemical Industries Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sanyo Chemical Industries Montelukast API Product Portfolio Table 84. Sanyo Chemical Industries Recent Development Table 85. Morepen Laboratories Company Information Table 86. Morepen Laboratories Business Overview Table 87. Morepen Laboratories Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Morepen Laboratories Montelukast API Product Portfolio Table 89. Morepen Laboratories Recent Development Table 90. Intas Pharmaceuticals Company Information Table 91. Intas Pharmaceuticals Business Overview Table 92. Intas Pharmaceuticals Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Intas Pharmaceuticals Montelukast API Product Portfolio Table 94. Intas Pharmaceuticals Recent Development Table 95. Delmar Chemicals Company Information Table 96. Delmar Chemicals Business Overview Table 97. Delmar Chemicals Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Delmar Chemicals Montelukast API Product Portfolio Table 99. Delmar Chemicals Recent Development Table 100. Cipla Company Information Table 101. Cipla Business Overview Table 102. Cipla Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Cipla Montelukast API Product Portfolio Table 104. Cipla Recent Development Table 105. Apotex Company Information Table 106. Apotex Business Overview Table 107. Apotex Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Apotex Montelukast API Product Portfolio Table 109. Apotex Recent Development Table 110. North America Montelukast API Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Montelukast API Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Montelukast API Sales by Type (2021-2026) & (K Units) Table 113. North America Montelukast API Sales by Type (2027-2032) & (K Units) Table 114. North America Montelukast API Sales Price by Type (2021-2026) & (US$/Unit) Table 115. North America Montelukast API Sales Price by Type (2027-2032) & (US$/Unit) Table 116. North America Montelukast API Revenue by Application (2021-2026) & (US$ Million) Table 117. North America Montelukast API Revenue by Application (2027-2032) & (US$ Million) Table 118. North America Montelukast API Sales by Application (2021-2026) & (K Units) Table 119. North America Montelukast API Sales by Application (2027-2032) & (K Units) Table 120. North America Montelukast API Sales Price by Application (2021-2026) & (US$/Unit) Table 121. North America Montelukast API Sales Price by Application (2027-2032) & (US$/Unit) Table 122. North America Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. North America Montelukast API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. North America Montelukast API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. North America Montelukast API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 126. North America Montelukast API Sales by Country (2021-2026) & (K Units) Table 127. North America Montelukast API Sales by Country (2027-2032) & (K Units) Table 128. North America Montelukast API Sales Price by Country (2021-2026) & (US$/Unit) Table 129. North America Montelukast API Sales Price by Country (2027-2032) & (US$/Unit) Table 130. United States Montelukast API Revenue (2021-2032) & (US$ Million) Table 131. Canada Montelukast API Revenue (2021-2032) & (US$ Million) Table 132. Europe Montelukast API Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Montelukast API Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Montelukast API Sales by Type (2021-2026) & (K Units) Table 135. Europe Montelukast API Sales by Type (2027-2032) & (K Units) Table 136. Europe Montelukast API Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Europe Montelukast API Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Europe Montelukast API Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Montelukast API Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Montelukast API Sales by Application (2021-2026) & (K Units) Table 141. Europe Montelukast API Sales by Application (2027-2032) & (K Units) Table 142. Europe Montelukast API Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Europe Montelukast API Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Europe Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Montelukast API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Europe Montelukast API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Europe Montelukast API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Europe Montelukast API Sales by Country (2021-2026) & (K Units) Table 149. Europe Montelukast API Sales by Country (2027-2032) & (K Units) Table 150. Europe Montelukast API Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Europe Montelukast API Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Germany Montelukast API Revenue (2021-2032) & (US$ Million) Table 153. France Montelukast API Revenue (2021-2032) & (US$ Million) Table 154. U.K. Montelukast API Revenue (2021-2032) & (US$ Million) Table 155. Italy Montelukast API Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Montelukast API Revenue (2021-2032) & (US$ Million) Table 157. Nordic Countries Montelukast API Revenue (2021-2032) & (US$ Million) Table 158. China Montelukast API Revenue by Type (2021-2026) & (US$ Million) Table 159. China Montelukast API Revenue by Type (2027-2032) & (US$ Million) Table 160. China Montelukast API Sales by Type (2021-2026) & (K Units) Table 161. China Montelukast API Sales by Type (2027-2032) & (K Units) Table 162. China Montelukast API Sales Price by Type (2021-2026) & (US$/Unit) Table 163. China Montelukast API Sales Price by Type (2027-2032) & (US$/Unit) Table 164. China Montelukast API Revenue by Application (2021-2026) & (US$ Million) Table 165. China Montelukast API Revenue by Application (2027-2032) & (US$ Million) Table 166. China Montelukast API Sales by Application (2021-2026) & (K Units) Table 167. China Montelukast API Sales by Application (2027-2032) & (K Units) Table 168. China Montelukast API Sales Price by Application (2021-2026) & (US$/Unit) Table 169. China Montelukast API Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Montelukast API Revenue by Type (2021-2026) & (US$ Million) Table 171. Asia Montelukast API Revenue by Type (2027-2032) & (US$ Million) Table 172. Asia Montelukast API Sales by Type (2021-2026) & (K Units) Table 173. Asia Montelukast API Sales by Type (2027-2032) & (K Units) Table 174. Asia Montelukast API Sales Price by Type (2021-2026) & (US$/Unit) Table 175. Asia Montelukast API Sales Price by Type (2027-2032) & (US$/Unit) Table 176. Asia Montelukast API Revenue by Application (2021-2026) & (US$ Million) Table 177. Asia Montelukast API Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Montelukast API Sales by Application (2021-2026) & (K Units) Table 179. Asia Montelukast API Sales by Application (2027-2032) & (K Units) Table 180. Asia Montelukast API Sales Price by Application (2021-2026) & (US$/Unit) Table 181. Asia Montelukast API Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Montelukast API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Asia Montelukast API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Asia Montelukast API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. Asia Montelukast API Sales by Country (2021-2026) & (K Units) Table 187. Asia Montelukast API Sales by Country (2027-2032) & (K Units) Table 188. Asia Montelukast API Sales Price by Country (2021-2026) & (US$/Unit) Table 189. Asia Montelukast API Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Japan Montelukast API Revenue (2021-2032) & (US$ Million) Table 191. South Korea Montelukast API Revenue (2021-2032) & (US$ Million) Table 192. India Montelukast API Revenue (2021-2032) & (US$ Million) Table 193. Australia Montelukast API Revenue (2021-2032) & (US$ Million) Table 194. China Taiwan Montelukast API Revenue (2021-2032) & (US$ Million) Table 195. Southeast Asia Montelukast API Revenue (2021-2032) & (US$ Million) Table 196. SAMEA Montelukast API Revenue by Type (2021-2026) & (US$ Million) Table 197. SAMEA Montelukast API Revenue by Type (2027-2032) & (US$ Million) Table 198. SAMEA Montelukast API Sales by Type (2021-2026) & (K Units) Table 199. SAMEA Montelukast API Sales by Type (2027-2032) & (K Units) Table 200. SAMEA Montelukast API Sales Price by Type (2021-2026) & (US$/Unit) Table 201. SAMEA Montelukast API Sales Price by Type (2027-2032) & (US$/Unit) Table 202. SAMEA Montelukast API Revenue by Application (2021-2026) & (US$ Million) Table 203. SAMEA Montelukast API Revenue by Application (2027-2032) & (US$ Million) Table 204. SAMEA Montelukast API Sales by Application (2021-2026) & (K Units) Table 205. SAMEA Montelukast API Sales by Application (2027-2032) & (K Units) Table 206. SAMEA Montelukast API Sales Price by Application (2021-2026) & (US$/Unit) Table 207. SAMEA Montelukast API Sales Price by Application (2027-2032) & (US$/Unit) Table 208. SAMEA Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. SAMEA Montelukast API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. SAMEA Montelukast API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. SAMEA Montelukast API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 212. SAMEA Montelukast API Sales by Country (2021-2026) & (K Units) Table 213. SAMEA Montelukast API Sales by Country (2027-2032) & (K Units) Table 214. SAMEA Montelukast API Sales Price by Country (2021-2026) & (US$/Unit) Table 215. SAMEA Montelukast API Sales Price by Country (2027-2032) & (US$/Unit) Table 216. Brazil Montelukast API Revenue (2021-2032) & (US$ Million) Table 217. Argentina Montelukast API Revenue (2021-2032) & (US$ Million) Table 218. Chile Montelukast API Revenue (2021-2032) & (US$ Million) Table 219. Colombia Montelukast API Revenue (2021-2032) & (US$ Million) Table 220. Peru Montelukast API Revenue (2021-2032) & (US$ Million) Table 221. Saudi Arabia Montelukast API Revenue (2021-2032) & (US$ Million) Table 222. Israel Montelukast API Revenue (2021-2032) & (US$ Million) Table 223. UAE Montelukast API Revenue (2021-2032) & (US$ Million) Table 224. Turkey Montelukast API Revenue (2021-2032) & (US$ Million) Table 225. Iran Montelukast API Revenue (2021-2032) & (US$ Million) Table 226. Egypt Montelukast API Revenue (2021-2032) & (US$ Million) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Montelukast API Distributors List Table 230. Montelukast API Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Montelukast API Image Figure 2. Global Montelukast API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chewable Tablet Image Figure 5. Oral Solution Image Figure 6. Tablet Image Figure 7. Global Montelukast API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Montelukast API Market Size Share 2021 VS 2025 VS 2032 Figure 9. Bronchospasm Image Figure 10. Urticaria Image Figure 11. Asthma Image Figure 12. Allergic Rhinitis Image Figure 13. Others Image Figure 14. Global Montelukast API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Montelukast API Revenue (2021-2032) & (US$ Million) Figure 16. Global Montelukast API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Montelukast API Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Montelukast API Revenue Market Share by Region (2021-2032) Figure 19. Global Montelukast API Sales (2021-2032) & (K Units) Figure 20. Global Montelukast API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Montelukast API Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Montelukast API Sales YoY (2021-2032) & (K Units) Figure 23. Europe Montelukast API Sales YoY (2021-2032) & (K Units) Figure 24. China Montelukast API Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Montelukast API Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Montelukast API Sales YoY (2021-2032) & (K Units) Figure 27. Global Montelukast API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Montelukast API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Montelukast API Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Montelukast API Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Montelukast API Revenue Market Share by Type (2021-2032) Figure 33. Global Montelukast API Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Montelukast API Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Montelukast API Sales Market Share by Type (2021-2032) Figure 36. Global Montelukast API Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Montelukast API Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Montelukast API Revenue Market Share by Application (2021-2032) Figure 39. Global Montelukast API Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Montelukast API Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Montelukast API Sales Market Share by Application (2021-2032) Figure 42. North America Montelukast API Revenue Share by Type (2021-2032) Figure 43. North America Montelukast API Sales Share by Type (2021-2032) Figure 44. North America Montelukast API Revenue Share by Application (2021-2032) Figure 45. North America Montelukast API Sales Share by Application (2021-2032) Figure 46. North America Montelukast API Revenue Share by Country (2021-2032) Figure 47. North America Montelukast API Sales Share by Country (2021-2032) Figure 48. Europe Montelukast API Revenue Share by Type (2021-2032) Figure 49. Europe Montelukast API Sales Share by Type (2021-2032) Figure 50. Europe Montelukast API Revenue Share by Application (2021-2032) Figure 51. Europe Montelukast API Sales Share by Application (2021-2032) Figure 52. Europe Montelukast API Revenue Share by Country (2021-2032) Figure 53. Europe Montelukast API Sales Share by Country (2021-2032) Figure 54. China Montelukast API Revenue Share by Type (2021-2032) Figure 55. China Montelukast API Sales Share by Type (2021-2032) Figure 56. China Montelukast API Revenue Share by Application (2021-2032) Figure 57. China Montelukast API Sales Share by Application (2021-2032) Figure 58. Asia Montelukast API Revenue Share by Type (2021-2032) Figure 59. Asia Montelukast API Sales Share by Type (2021-2032) Figure 60. Asia Montelukast API Revenue Share by Application (2021-2032) Figure 61. Asia Montelukast API Sales Share by Application (2021-2032) Figure 62. Asia Montelukast API Revenue Share by Country (2021-2032) Figure 63. Asia Montelukast API Sales Share by Country (2021-2032) Figure 64. SAMEA Montelukast API Revenue Share by Type (2021-2032) Figure 65. SAMEA Montelukast API Sales Share by Type (2021-2032) Figure 66. SAMEA Montelukast API Revenue Share by Application (2021-2032) Figure 67. SAMEA Montelukast API Sales Share by Application (2021-2032) Figure 68. SAMEA Montelukast API Revenue Share by Country (2021-2032) Figure 69. SAMEA Montelukast API Sales Share by Country (2021-2032) Figure 70. Montelukast API Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Montelukast API Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Chewable Tablet
  • Oral Solution
  • Tablet
Applications
  • Bronchospasm
  • Urticaria
  • Asthma
  • Allergic Rhinitis
  • Others
Companies covered
  • Merck
  • Mylan
  • Teva Pharmaceutical Industries
  • Sun Pharma
  • Sanyo Chemical Industries
  • Morepen Laboratories
  • Intas Pharmaceuticals
  • Delmar Chemicals
  • Cipla
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Montelukast API Market by Type
  3. 1.2.1 Global Montelukast API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chewable Tablet
  5. 1.2.3 Oral Solution
  6. 1.2.4 Tablet
  7. 1.3 Montelukast API Market by Application
  8. 1.3.1 Global Montelukast API Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Bronchospasm
  10. 1.3.3 Urticaria
  11. 1.3.4 Asthma
  12. 1.3.5 Allergic Rhinitis
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Montelukast API Market Dynamics
  1. 2.1 Montelukast API Industry Trends
  2. 2.2 Montelukast API Industry Drivers
  3. 2.3 Montelukast API Industry Opportunities and Challenges
  4. 2.4 Montelukast API Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Montelukast API Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Montelukast API Revenue by Region
  3. 3.2.1 Global Montelukast API Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Montelukast API Revenue by Region (2021-2026)
  5. 3.2.3 Global Montelukast API Revenue by Region (2027-2032)
  6. 3.2.4 Global Montelukast API Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Montelukast API Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Montelukast API Sales by Region
  9. 3.4.1 Global Montelukast API Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Montelukast API Sales by Region (2021-2026)
  11. 3.4.3 Global Montelukast API Sales by Region (2027-2032)
  12. 3.4.4 Global Montelukast API Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Montelukast API Revenue by Manufacturers
  2. 4.1.1 Global Montelukast API Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Montelukast API Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Montelukast API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Montelukast API Sales by Manufacturers
  6. 4.2.1 Global Montelukast API Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Montelukast API Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Montelukast API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Montelukast API Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Montelukast API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Montelukast API Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Montelukast API Manufacturers, Product Type & Application
  13. 4.7 Global Montelukast API Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Montelukast API Market CR5 and HHI
  16. 4.8.2 2025 Montelukast API Tier 1, Tier 2, and Tier 3
5 Montelukast API Market by Type
  1. 5.1 Global Montelukast API Revenue by Type
  2. 5.1.1 Global Montelukast API Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Montelukast API Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Montelukast API Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Montelukast API Sales by Type
  6. 5.2.1 Global Montelukast API Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Montelukast API Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Montelukast API Sales Market Share by Type (2021-2032)
  9. 5.3 Global Montelukast API Price by Type
6 Montelukast API Market by Application
  1. 6.1 Global Montelukast API Revenue by Application
  2. 6.1.1 Global Montelukast API Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Montelukast API Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Montelukast API Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Montelukast API Sales by Application
  6. 6.2.1 Global Montelukast API Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Montelukast API Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Montelukast API Sales Market Share by Application (2021-2032)
  9. 6.3 Global Montelukast API Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Montelukast API Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Montelukast API Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 Teva Pharmaceutical Industries
  14. 7.3.1 Teva Pharmaceutical Industries Company Information
  15. 7.3.2 Teva Pharmaceutical Industries Business Overview
  16. 7.3.3 Teva Pharmaceutical Industries Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Teva Pharmaceutical Industries Montelukast API Product Portfolio
  18. 7.3.5 Teva Pharmaceutical Industries Recent Developments
  19. 7.4 Sun Pharma
  20. 7.4.1 Sun Pharma Company Information
  21. 7.4.2 Sun Pharma Business Overview
  22. 7.4.3 Sun Pharma Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sun Pharma Montelukast API Product Portfolio
  24. 7.4.5 Sun Pharma Recent Developments
  25. 7.5 Sanyo Chemical Industries
  26. 7.5.1 Sanyo Chemical Industries Company Information
  27. 7.5.2 Sanyo Chemical Industries Business Overview
  28. 7.5.3 Sanyo Chemical Industries Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanyo Chemical Industries Montelukast API Product Portfolio
  30. 7.5.5 Sanyo Chemical Industries Recent Developments
  31. 7.6 Morepen Laboratories
  32. 7.6.1 Morepen Laboratories Company Information
  33. 7.6.2 Morepen Laboratories Business Overview
  34. 7.6.3 Morepen Laboratories Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Morepen Laboratories Montelukast API Product Portfolio
  36. 7.6.5 Morepen Laboratories Recent Developments
  37. 7.7 Intas Pharmaceuticals
  38. 7.7.1 Intas Pharmaceuticals Company Information
  39. 7.7.2 Intas Pharmaceuticals Business Overview
  40. 7.7.3 Intas Pharmaceuticals Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Intas Pharmaceuticals Montelukast API Product Portfolio
  42. 7.7.5 Intas Pharmaceuticals Recent Developments
  43. 7.8 Delmar Chemicals
  44. 7.8.1 Delmar Chemicals Company Information
  45. 7.8.2 Delmar Chemicals Business Overview
  46. 7.8.3 Delmar Chemicals Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Delmar Chemicals Montelukast API Product Portfolio
  48. 7.8.5 Delmar Chemicals Recent Developments
  49. 7.9 Cipla
  50. 7.9.1 Cipla Company Information
  51. 7.9.2 Cipla Business Overview
  52. 7.9.3 Cipla Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Cipla Montelukast API Product Portfolio
  54. 7.9.5 Cipla Recent Developments
  55. 7.10 Apotex
  56. 7.10.1 Apotex Company Information
  57. 7.10.2 Apotex Business Overview
  58. 7.10.3 Apotex Montelukast API Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Apotex Montelukast API Product Portfolio
  60. 7.10.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Montelukast API Market Size by Type
  2. 8.1.1 North America Montelukast API Revenue by Type (2021-2032)
  3. 8.1.2 North America Montelukast API Sales by Type (2021-2032)
  4. 8.1.3 North America Montelukast API Price by Type (2021-2032)
  5. 8.2 North America Montelukast API Market Size by Application
  6. 8.2.1 North America Montelukast API Revenue by Application (2021-2032)
  7. 8.2.2 North America Montelukast API Sales by Application (2021-2032)
  8. 8.2.3 North America Montelukast API Price by Application (2021-2032)
  9. 8.3 North America Montelukast API Market Size by Country
  10. 8.3.1 North America Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Montelukast API Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Montelukast API Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Montelukast API Market Size by Type
  2. 9.1.1 Europe Montelukast API Revenue by Type (2021-2032)
  3. 9.1.2 Europe Montelukast API Sales by Type (2021-2032)
  4. 9.1.3 Europe Montelukast API Price by Type (2021-2032)
  5. 9.2 Europe Montelukast API Market Size by Application
  6. 9.2.1 Europe Montelukast API Revenue by Application (2021-2032)
  7. 9.2.2 Europe Montelukast API Sales by Application (2021-2032)
  8. 9.2.3 Europe Montelukast API Price by Application (2021-2032)
  9. 9.3 Europe Montelukast API Market Size by Country
  10. 9.3.1 Europe Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Montelukast API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Montelukast API Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Montelukast API Market Size by Type
  2. 10.1.1 China Montelukast API Revenue by Type (2021-2032)
  3. 10.1.2 China Montelukast API Sales by Type (2021-2032)
  4. 10.1.3 China Montelukast API Price by Type (2021-2032)
  5. 10.2 China Montelukast API Market Size by Application
  6. 10.2.1 China Montelukast API Revenue by Application (2021-2032)
  7. 10.2.2 China Montelukast API Sales by Application (2021-2032)
  8. 10.2.3 China Montelukast API Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Montelukast API Market Size by Type
  2. 11.1.1 Asia Montelukast API Revenue by Type (2021-2032)
  3. 11.1.2 Asia Montelukast API Sales by Type (2021-2032)
  4. 11.1.3 Asia Montelukast API Price by Type (2021-2032)
  5. 11.2 Asia Montelukast API Market Size by Application
  6. 11.2.1 Asia Montelukast API Revenue by Application (2021-2032)
  7. 11.2.2 Asia Montelukast API Sales by Application (2021-2032)
  8. 11.2.3 Asia Montelukast API Price by Application (2021-2032)
  9. 11.3 Asia Montelukast API Market Size by Country
  10. 11.3.1 Asia Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Montelukast API Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Montelukast API Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Montelukast API Market Size by Type
  2. 12.1.1 SAMEA Montelukast API Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Montelukast API Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Montelukast API Price by Type (2021-2032)
  5. 12.2 SAMEA Montelukast API Market Size by Application
  6. 12.2.1 SAMEA Montelukast API Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Montelukast API Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Montelukast API Price by Application (2021-2032)
  9. 12.3 SAMEA Montelukast API Market Size by Country
  10. 12.3.1 SAMEA Montelukast API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Montelukast API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Montelukast API Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Montelukast API Value Chain Analysis
  2. 13.1.1 Montelukast API Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Montelukast API Production Mode & Process
  6. 13.2 Montelukast API Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Montelukast API Distributors
  9. 13.2.3 Montelukast API Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst